Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Parkinsonism & Related Disorders|March 14, 2019
French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS)Ana Marques, Tiphaine Vidal, Bruno Pereira, et al.NPJ Parkinson'S Disease|April 27, 2026
Elevated levels of colonic interleukin-1beta and interleukin-8 in isolated REM sleep behavior disorder without associated changes in permeabilityLoïc Sellier Montaigne, Simon Lassozé, Adrien de Guilhem de Lataillade, et al.Plos One|October 2, 2010
Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?Yulia Worbe, Luc Mallet, Jean-Louis Golmard, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 15, 2005
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinasePascal Derkinderen, Timothy M E Scales, Diane P Hanger, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2019
Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal StudyPei-Chen Lee, Fanny Artaud, Florence Cormier-Dequaire, et al.Neurology|June 22, 2018
Longitudinal analysis of impulse control disorders in Parkinson diseaseJean-Christophe Corvol, Fanny Artaud, Florence Cormier-Dequaire, et al.Brain : a Journal of Neurology|May 8, 2020
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primatesMarie-Laure Arotcarena, Sandra Dovero, Alice Prigent, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2015
Delayed-onset Friedreich's ataxia revisitedClaire Lecocq, Perrine Charles, Jean-Philippe Azulay, et al.Scientific Reports|December 11, 2020
Analysis of enteric nervous system and intestinal epithelial barrier to predict complications in Hirschsprung's diseaseAnne Dariel, Lucie Grynberg, Marie Auger, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.Pageof 12